Top Drug Delivery Device Solution Companies
List of Top Drug Delivery Device Solution Companies
Drug delivery is the method or process of administering a pharmaceutical compound to attain a therapeutic effect in humans or animals. For the treatment of human diseases, nasal and pulmonary routes of drug delivery are gaining increasing importance. These routes provide promising alternatives to parenteral drug delivery, particularly for peptide and protein therapeutics. For this purpose, several drug delivery systems are formulated and are being investigated for nasal and pulmonary delivery.
The pharmaceutical and biotechnology domains have come an extended way in advancing drug discovery today. Novel druggable targets and new mechanistic approaches to treat even complex diseases are continually being developed and optimized, generating an expensive therapeutics pipeline. To perfect the delivery of those therapeutics to the patients, subsequent innovations are being made within the drug delivery systems and technologies. The following generation of drug delivery technologies is being created to translate the scientific progress underpinning new modalities into clinical benefits for the patients.
Scientists are noticeably committed today to interrupt the barriers between the new drugs and their targets in tissues and cells. A broad range of nanoparticles is being developed, which will deliver drugs to previously undruggable targets and precisely control the discharge of medicine in formulations convenient for the patients. They’re also investigating other innovative ways to deliver therapeutics. For example, micro-patch technology is being employed today to administer solid dose therapeutics.
A recent study at Washington University in St. Louis showed that microbubble technology could bypass the barrier. The researchers thus demonstrated a replacement thanks to delivering drugs to the brainstem — a non-invasive administration using microbubbles and ultrasound. Here, the microbubbles work as a contrast agent within the ultrasound to reinforce the transfer of intranasally administered drugs. Similarly, milk-derived exosome platforms are utilized today to make oral formulations of antisense drugs. The platform can produce exosomes within which small molecules or biologics may well be packed and administered orally.
At this juncture, there’s a range of drug delivery device solution providers available within the market that cater to the various needs of the pharmaceutical companies. The enlisted solution providers are the frontrunners within the market that provide a large span of features. To assist them in choosing the answer provider that most closely fits their requirement, MedTech Outlook has compiled a listing of the highest 10 drug delivery device solution providers. Besides, the magazine also comprises insights from thought leaders within the sector on the industry trends, best practices, recent innovations, and their advice for the aspiring CXOs.
Top Drug Delivery Device Solution Companies:
Iconovo
Iconovo is a Sweden-based pharmaceuticals company that develops ready-to-use inhalation products — inhaler devices and dry powder formulations — and assists in clinical trials and registration for generic drug and pharmaceutical companies. Possessing a unique combination of engineering and pharmaceutical expertise, the company renders an integrated development process that enables it to develop devices and formulations in a shorter time-frame cost-efficiently, meeting the rigorous ISO 13485-standard. Iconovo has four proprietary inhaler platforms — ICOres, ICOpre, ICOcap, and ICOon
Arx
As a leading industry expert on drug-containing dissolvable film technology and transdermal patch drug delivery systems, including oral thin film, mucosal thin film, sublingual drug delivery, and buccal drug delivery, as well as transdermal patch dosage forms, ARx is an innovative drug development and manufacturing partner for novel drug products. The work of ARx expands delivery possibilities for new or existing drug products by enhancing bioavailability and increasing patient compliance. The result is enriched patient well-being through robust drug delivery systems
Caisson Biotech
Caisson Biotech is a collaboration driven biotechnology company specializing in the development of heparosan polymers to improve therapeutic drug delivery and performance. Caisson Biotech has developed a novel heparosan-based drug delivery platform, Heptune, to enhance the performance of therapeutics. Heparosan is a naturally occurring sugar polymer with low risk of toxicity and immunogenicity
E3D Elcam Drug Delivery Devices
E3D specializes in developing and manufacturing auto-injectors and other drug delivery devices for conventional drugs, biologic products and biosimilar drugs. Our auto-injectors operate with injectable drugs in vials, prefilled syringes and cartridges. In addition, we offer disposable and reusable auto-injectors and patch pumps. One of our major areas of expertise is customization of devices to meet the customer’s exact needs. E3D is part of the Elcam Medical, a world leader in OEM disposable medical devices
Lipidor
Lipidor is a Swedish, Stockholm-based research and development company with a pipeline of pharmaceutical development projects in preclinical and clinical phases. The Company develops topical medical products for the treatment of diseases such as psoriasis, bacterial skin infections and atopic dermatitis by reformulation of proven pharmaceutical substances
Nanoshell Company
Nanoshell Company translates the benefits of nanotechnology into practical solutions for biomedical, research and commercial needs. We specialize in the design, manufacture and integration of functional nanomaterials into products and transformation systems. Our unique nanomaterials are ready to integrate into new products including food packaging, nutraceuticals, personal care products and supplements
PassPort Technologies
Offers a novel active transdermal technology for transdermal needle-free administration of drugs that have been limited to injections or infusions
PCI Biotech
PCI Biotech (OSE:PCIB) is a biopharmaceutical company focusing on development and commercialisation of novel therapeutic solutions for improved treatment of cancer patients through its innovative photochemical internalisation (PCI) technology platform. PCI induces triggered endosomal release that can be used to unlock the true potential of a wide array of therapeutic modalities. The company’s lead fimaChem programme consists of a pivotal clinical study with registration intent of Amphinex® in bile duct cancer, an orphan indication with a high-unmet need and without approved products. Clinical proof-of-concept has been achieved in the fimaVacc programme, which applies a unique mode of action to enhance the essential cytotoxic effect of therapeutic cancer vaccines. The fimaNAc programme utilises the triggered endosomal release to provide effective intracellular delivery of nucleic acids, such as mRNA and siRNA therapeutics, thereby addressing one of the major bottlenecks facing this emerging and promising class of therapeutics.
PharmaCircle
PharmaCircle is a leading provider of authoritative information, global insight, and expert analysis on the pharmaceutical, biotech, drug delivery technology and device, and animal health industries. PharmaCircle’s premier database tracks drugs, biologics and combination products in all stages of development, connecting pipeline and product information with formulation and component details. The database delivers seamless integration of scientific, clinical, safety, regulatory, manufacturing and commercial information, and detailed analysis on over 7,000 drug delivery technologies and delivery devices
Quantex Arc
Quantex is the innovative leader in single-use disposable pump technology. We provide a catalogue of single-use pumps and also provide a design and development service for custom applications. Our engineers and designers are on hand to provide design expertise throughout the development programme and assistance into volume production .
